Cancer Research Technology
Log in Register
Menu

Anti-PCNA [5E6/2]
RECENTLY UPDATED

Info

Catalogue Number 151456
Applications ELISA IP WB
Antigen/Gene or Protein Targets Proliferating cell nuclear antigen, (PCNA), also known as cyclin or polymerase delta accessory protein.
Reactivity Saccharomyces cerevisiae
Relevance
RECENTLY UPDATED
Monoclonal antibody which binds PCNA, a tumour proliferation marker.

Background and Research Application
PCNA, also known as polymerase delta auxiliary protein, is essential for DNA replication and is involved in DNA excision and mismatch repair pathways. It is required for cellular DNA synthesis, and in vitro replication of SV40 DNA. It helps to co-ordinate the leading and lagging strand synthesis at the replication fork. PCNA binds to the CDK inhibitor p21, the structure-specific endonucleases Fen1 and XPG, and DNA cytosine 5-methyltransferase (MCMT). PCNA is the replicative clamp protein, an essential processivity factor for DNA polymerases and an interaction partner for many other proteins. This protein is potentially a therapeutic target in cancer therapy and a useful marker for identifying the proliferation status of tumour tissue (i.e. relevant to prognosis).
This antibody recognises endogenous PCNA protein from budding yeast, Sacchoromyces cerevisiae.
Host Mouse
Immunogen Purified recombinant His6-POL30 (PCNA) from budding yest, Saccharomyces cerevisiae, produced in Escherichia coli
Immunogen UniProt ID
RECENTLY UPDATED
P12004
Positive Control Wild type budding yeast expressing native POL30 (PCNA)
Subclass
RECENTLY UPDATED
IgG1
Molecular Weight (kDa) 30
Myeloma Used Sp2/0-Ag14
Recommended Growing Conditions RPMI + 5% FCS
Strain CD1
Notes
RECENTLY UPDATED
Production Details
Purified using multi-step affinity chromatography with protein A.

Storage Conditions
Store at -20 degrees frozen. Avoid repeated freeze/thaw cycles.

Concentration
1mg/ml as standard
Research Area
RECENTLY UPDATED
Cancer, Cell Cycle, Cell Type or Organelle Marker, Epigenetics & Nuclear Signalling

References

There are 9 reference entries for this reagent.

View All References

References: 9 entries
RECENTLY UPDATED

Schalbetter et al. 2015. Proc Natl Acad Sci U S A. 112(33):E4565-70. PMID: 26240319.

Kubota et al. 2011. Mol Cell Proteomics. 10(7):M110.005561. PMID: 21505101.

Quantitative proteomic analysis of chromatin reveals that Ctf18 acts in the DNA replication checkpoint.

Europe PMC ID: 21505101

Parker et al. 2008. EMBO J. 27(18):2422-31. PMID: 18701921.

SUMO modification of PCNA is controlled by DNA.

Europe PMC ID: 18701921

Davies et al. 2008. Mol Cell. 29(5):625-36. PMID: 18342608.

Activation of ubiquitin-dependent DNA damage bypass is mediated by replication protein a.

Europe PMC ID: 18342608

Windecker et al. 2008. J Mol Biol. 376(1):221-31. PMID: 18155241.

Architecture and assembly of poly-SUMO chains on PCNA in Saccharomyces cerevisiae.

Europe PMC ID: 18155241


Add a reference

References: 9 entries
RECENTLY UPDATED

Schalbetter et al. 2015. Proc Natl Acad Sci U S A. 112(33):E4565-70. PMID: 26240319.

Kubota et al. 2011. Mol Cell Proteomics. 10(7):M110.005561. PMID: 21505101.

Quantitative proteomic analysis of chromatin reveals that Ctf18 acts in the DNA replication checkpoint.

Parker et al. 2008. EMBO J. 27(18):2422-31. PMID: 18701921.

SUMO modification of PCNA is controlled by DNA.

Davies et al. 2008. Mol Cell. 29(5):625-36. PMID: 18342608.

Activation of ubiquitin-dependent DNA damage bypass is mediated by replication protein a.

Windecker et al. 2008. J Mol Biol. 376(1):221-31. PMID: 18155241.

Architecture and assembly of poly-SUMO chains on PCNA in Saccharomyces cerevisiae.


Add a reference

Inventor Information